Antineoplastic agents, 122. Constituents of Combretum caffrum
- PMID: 3668557
- DOI: 10.1021/np50051a008
Antineoplastic agents, 122. Constituents of Combretum caffrum
Abstract
An investigation of the South African tree Combretum caffrum (Combretaceae) for antineoplastic constituents was conducted by employing the astrocytoma bioassay (9ASK). By this approach and a combination of solvent partition, steric exclusion, and adsorption chromatographic procedures, a substance designated combretastatin [1a] was isolated and found to display significant (71-90% astrocyte reversal at 1-100 micrograms/ml dose levels) astrocyte reversal and murine P-388 lymphocytic leukemia (PS) cell growth inhibition (ED50 0.011 micrograms/ml). The structure of (-)-combretastatin was elucidated by X-ray crystal structure analysis and confirmed by total synthesis. The absolute configuration at C-10 was assigned the R-configuration on the basis of Horeau esterification techniques. Other prominent, albeit PS-inactive, constituents were found to be 3,3',4'-tri-O-methylellagic acid [2] and acacetin [3].
Similar articles
-
Isolation, structure, and synthesis of combretastatins A-1 and B-1, potent new inhibitors of microtubule assembly, derived from Combretum caffrum.J Nat Prod. 1987 Jan-Feb;50(1):119-31. doi: 10.1021/np50049a016. J Nat Prod. 1987. PMID: 3598594
-
Isolation, structure, synthesis, and antimitotic properties of combretastatins B-3 and B-4 from Combretum caffrum.J Nat Prod. 1988 May-Jun;51(3):517-27. doi: 10.1021/np50057a011. J Nat Prod. 1988. PMID: 3404149
-
Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4.Experientia. 1989 Feb 15;45(2):209-11. doi: 10.1007/BF01954881. Experientia. 1989. PMID: 2920809
-
Combretastatins: from natural products to drug discovery.Nat Prod Rep. 2003 Dec;20(6):558-64. doi: 10.1039/b306797c. Nat Prod Rep. 2003. PMID: 14700199 Review.
-
Combretastatin A-4 analogues as antimitotic antitumor agents.Curr Med Chem. 2003 Sep;10(17):1697-722. doi: 10.2174/0929867033457151. Curr Med Chem. 2003. PMID: 12871118 Review.
Cited by
-
Bioreductively activatable prodrug conjugates of phenstatin designed to target tumor hypoxia.Bioorg Med Chem Lett. 2017 Feb 1;27(3):636-641. doi: 10.1016/j.bmcl.2016.11.093. Epub 2016 Dec 1. Bioorg Med Chem Lett. 2017. PMID: 28007448 Free PMC article.
-
Polygamain, a new microtubule depolymerizing agent that occupies a unique pharmacophore in the colchicine site.Mol Pharmacol. 2012 Mar;81(3):431-9. doi: 10.1124/mol.111.075838. Epub 2011 Dec 14. Mol Pharmacol. 2012. PMID: 22169850 Free PMC article.
-
High-affinity ligands of the colchicine domain in tubulin based on a structure-guided design.Sci Rep. 2018 Mar 9;8(1):4242. doi: 10.1038/s41598-018-22382-x. Sci Rep. 2018. PMID: 29523799 Free PMC article.
-
Secondary metabolites as DNA topoisomerase inhibitors: A new era towards designing of anticancer drugs.Pharmacogn Rev. 2010 Jan;4(7):12-26. doi: 10.4103/0973-7847.65320. Pharmacogn Rev. 2010. PMID: 22228937 Free PMC article.
-
Bioactivities of the genus Combretum (Combretaceae): a review.Molecules. 2012 Aug 2;17(8):9142-206. doi: 10.3390/molecules17089142. Molecules. 2012. PMID: 22858840 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources